blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4218816

EP4218816 - PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.03.2024
Database last updated on 13.07.2024
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2023/31]
Inventor(s)01 / YONEYAMA, Koichiro
Tokyo, 103-8324 / JP
 [2023/31]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2023/31]
Application number, filing date23157462.531.03.2015
[2023/31]
Priority number, dateJP2014012724020.06.2014         Original published format: JP 2014127240
JP2014022698807.11.2014         Original published format: JP 2014226988
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4218816
Date:02.08.2023
Language:EN
[2023/31]
Type: A3 Search report 
No.:EP4218816
Date:13.09.2023
Language:EN
[2023/37]
Search report(s)(Supplementary) European search report - dispatched on:EP11.08.2023
ClassificationIPC:A61K39/395, A61P7/04, C07K16/36, C07K16/46
[2023/31]
CPC:
A61P7/04 (EP,KR,RU); A61K39/395 (IL,RU,US); C07K16/36 (EP,IL,KR,US);
C07K16/46 (IL,US); A61K2039/505 (EP,KR,US); A61K2039/545 (EP,KR);
C07K2317/31 (EP,KR,US); C07K2317/51 (US); C07K2317/515 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/16]
Former [2023/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON KRANKHEITEN, DIE SICH ENTWICKELN ODER VERMEHREN AUFGRUND VON BLUTGERINNUNGSFAKTOR VIII UND/ODER AKTIVIERTEM BLUTGERINNUNGSFAKTOR VIII[2023/31]
English:PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII[2023/31]
French:COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET/OU LE TRAITEMENT D'UNE MALADIE QUI SE DEVELOPPE OU SE PROGRESSION[2023/31]
Examination procedure11.03.2024Amendment by applicant (claims and/or description)
11.03.2024Examination requested  [2024/16]
11.03.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP15809216.3  / EP3159006
Fees paidRenewal fee
20.03.2023Renewal fee patent year 03
20.03.2023Renewal fee patent year 04
20.03.2023Renewal fee patent year 05
20.03.2023Renewal fee patent year 06
20.03.2023Renewal fee patent year 07
20.03.2023Renewal fee patent year 08
22.03.2023Renewal fee patent year 09
27.03.2024Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP2644698  (CHUGAI PHARMACEUTICAL CO LTD [JP]);
by applicantUS3773919
 EP0058481
 EP0133988
 EP0239400
 WO9203918
 WO9312227
 WO9402602
 WO9425585
 WO9501937
 WO9602576
 WO9634096
 WO9633735
 WO9951743
 WO0220565
 WO0232925
 WO2004044011
 WO2005035754
 WO2005035756
 WO2005040229
 WO2006109592
 WO2011090088
 WO2012067176
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.